Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 27/03/2012
PIL TOVIAZ 4 mg prolonged-release tablets & TOVIAZ 8 mg prolonged-release tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 28/10/2011 and displayed until 27/03/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 01/04/2011 and displayed until 28/10/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
  • Change to drug interactions
Updated on 24/02/2011 and displayed until 01/04/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 11/02/2011 and displayed until 24/02/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to MA holder contact details
  • Change to date of revision
Updated on 08/07/2010 and displayed until 11/02/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 17/07/2009 and displayed until 08/07/2010
Reasons for adding or updating:
  • Introduction of new pack/pack size
Updated on 25/03/2009 and displayed until 17/07/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 11/03/2009 and displayed until 25/03/2009
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 29/01/2009 and displayed until 11/03/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 21/01/2009 and displayed until 29/01/2009
Reasons for adding or updating:
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 27/06/2008 and displayed until 21/01/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  fesoterodine fumarate